CWM
PVLA

CIBC World Markets’s Palvella Therapeutics PVLA Stock Holding History

CIBC World Markets’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-666
Closed -$179K – 750
2019
Q1 		$179K Hold
666
– – ﹤0.01% 638
2018
Q4 		$142K Sell
666
-2,124
-76% -$659K ﹤0.01% 603
2018
Q3 		$1.25M Sell
2,790
-341
-11% -$148K 0.01% 590
2018
Q2 		$1.27M Sell
3,131
-1,158
-27% -$551K 0.01% 637
2018
Q1 		$2.34M Buy
+4,289
New +$2.65M 0.02% 462

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

CIBC World Markets's PVLA Position: Q2 2019 in Review

CIBC World Markets sold out of Palvella Therapeutics (PVLA) in Q2 2019, closing a stake of 666 shares — an estimated $179K sold.

CIBC World Markets first reported a position in PVLA in Q1 2018 and held it in 5 quarters. The position peaked at $2.34M in Q1 2018. 93 funds tracked by Wall St. Rank hold PVLA as of Q2 2019.

  • CIBC World Markets reported no remaining Palvella Therapeutics position as of Q2 2019 after selling out during the quarter.
  • CIBC World Markets sold 666 Palvella Therapeutics shares in Q2 2019, an estimated $179K.
  • CIBC World Markets first reported a position in Palvella Therapeutics in Q1 2018 and held it in 5 quarters.
  • CIBC World Markets's Palvella Therapeutics position peaked at $2.34M in Q1 2018.
  • 93 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2019.

Based on CIBC World Markets's 13F filing for Q2 2019, filed 13 Aug 2019.